MyBlueDotsHedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing MyBlueDots6 months ago01 mins COPENHAGEN, Denmark & PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes. Post navigation Previous: Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025Next: BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
New insights into malaria: Proteins in the blood can reveal the severity of the disease MyBlueDots7 hours ago 0
Inequality, pollution, and democracy levels shape how quickly populations age: Study MyBlueDots7 hours ago 0
Novel open-source diagnostic tool offers affordable, reliable pathogen detection for resource-limited settings MyBlueDots8 hours ago 0